Björn Cochlovius
Presidente presso BIOCURE TECHNOLOGY INC.
Posizioni attive di Björn Cochlovius
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOCURE TECHNOLOGY INC. | Presidente | 22/07/2021 | - |
| Medraxa Therapeutics GmbH | Amministratore Delegato | - | - |
| BC Biomed Consulting GmbH | Amministratore Delegato | - | - |
Eleva GmbH
 Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany. | Amministratore Delegato | 03/05/2023 | - |
| Ruprecht-Karls-Universität Heidelberg | Corporate Officer/Principal | 01/05/2003 | - |
Storia della carriera di Björn Cochlovius
Precedenti posizioni note di Björn Cochlovius
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KAROLINSKA DEVELOPMENT AB | Direttore/Membro del Consiglio | 01/06/2020 | 19/02/2021 |
| Presidente | 19/02/2021 | 01/05/2024 | |
Sapreme Technologies BV
 Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Presidente | 17/12/2020 | 01/02/2024 |
| Independent Dir/Board Member | 17/12/2020 | 01/02/2024 | |
| ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
Ciliatech Therapeutics AG
 Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Ciliatech Therapeutics AG is a Swiss company that focuses on researching, developing, producing, and distributing pharmaceutical and diagnostic products. | Amministratore Delegato | - | - |
| Presidente | - | - | |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Björn Cochlovius
| Universität des Saarlandes | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 7 |
| Stati Uniti | 3 |
| Norvegia | 2 |
Posizioni
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Corporate Officer/Principal | 4 |
Settori
| Health Technology | 9 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| BIOCURE TECHNOLOGY INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Aziende private | 9 |
|---|---|
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Commercial Services |
Sapreme Technologies BV
Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Health Technology |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
| Medraxa Therapeutics GmbH | |
| BC Biomed Consulting GmbH | |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
Ciliatech Therapeutics AG
Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Ciliatech Therapeutics AG is a Swiss company that focuses on researching, developing, producing, and distributing pharmaceutical and diagnostic products. | Health Technology |
Eleva GmbH
Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany. | Health Technology |
- Borsa valori
- Insiders
- Björn Cochlovius
- Esperienza
